Tradestie Institutional Equity Comparison Engine
AGMB vs EVMN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EVMN Overall Edge
EVMN Captures Institutional Edge (3โ0 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evommune, Inc. (EVMN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AGMB trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus EVMN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AGMB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EVMN sits in SURGE (67th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
AGMB N/M vs EVMN N/M Fwd P/E
Growth & Margin Winner
EVMN
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
EVMN
1Y -58.6% vs -60.3% ยท 52W Pos 3% vs 8%
Options & Structure Winner
EVMN
UNCLASSIFIED (N/A IV) vs SURGE (67th %ile IV)
AGMB
US Equity
AGMB
Institutional Equity
$6.07
-4.64% 1D
Market Cap
N/A
1M Return
-26.75%
1Y Return
-58.6%
Forward P/E
N/M
Unified AI Score
40.9 / 100
SELL
Tech 25.0
Fund 43.0
Flow 50.0
Mom 59.0
EVMN
US Equity
Evommune, Inc.
Pharmaceutical Preparations
$7.24
-5.11% 1D
Market Cap
$291.1M
1M Return
+40.04%
1Y Return
-60.26%
Forward P/E
N/M
Unified AI Score
30.0 / 100
SELL
Tech 50.0
Fund 35.0
Flow 69.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AGMB -58.6%
EVMN -60.26%
Spread: +0.43 pp (EVMN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AGMB TTM Op. Margin: N/A
EVMN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AGMB vs EVMN. Trailing 12-month operating profitability (AGMB N/A vs EVMN 0.0%) and valuation multiples (AGMB N/M vs EVMN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AGMB | EVMN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $291.1M | Larger Scale | EVMN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | EVMN |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | EVMN |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | EVMN |
| Return on Equity (ROE) Capital Efficiency | N/A | -69.5% | Higher ROE | EVMN |
| 52-Week Range Position Momentum | 3% ($6โ$18) | 8% ($5โ$33) | Stronger Trend | EVMN |
| Beta / 30D Volatility Risk Regime | 1.44ฮฒ ยท 78% Vol | 1.05ฮฒ ยท 118% Vol | Lower Realized Risk | AGMB |
| Unified Institutional Score Composite Signal | 40.9 / 100 (SELL) | 30.0 / 100 (SELL) | Higher Composite | AGMB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AGMB vs EVMN Buy Guide
AGMB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
EVMN
SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
67th %ile
IV Regime
Elevated (60thโ80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AGMB nor EVMN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.